Nephrology

Back to articles

Benefits and harms of osteoporosis medications in patients with CKD unclear

KEY POINT

The safety and beneficial effects of osteoporosis medications on bone mineral density (BMD) and fracture risk in patients with chronic kidney disease (CKD) are unclear, according to results of a systematic review and meta-analysis published in the Annals of Internal Medicine.